ロード中...
Antiphospholipid Antibodies and Systemic Scleroderma
Objective: Antiphospholipid antibodies (APLs) could be associated with an increased risk of vascular pathologies in systemic scleroderma. The aim of our study was to search for APLs in patients affected by systemic scleroderma and to evaluate their involvement in the clinical manifestations of this...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Galenos Publishing
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3781654/ https://ncbi.nlm.nih.gov/pubmed/24385750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.2012.0059 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|